This post was originally published on this siteThis post was originally published on this site GBR 1342, an investigational bispecific antibody developed by ... Read more

This post was originally published on this siteThis post was originally published on this site Ygalo (melflufen) combination therapy continues to demonstrate promising ... Read more

This post was originally published on this siteThis post was originally published on this site Designing CAR T-cells to specifically target GPRC5D — a ... Read more

This post was originally published on this siteThis post was originally published on this site Henry Schein, a foundation devoted to promoting dental ... Read more

This post was originally published on this siteThis post was originally published on this site The addition of Keytruda (pembrolizumab) to standard therapy ... Read more

This post was originally published on this siteThis post was originally published on this site Shlomit Norman was 42 when doctors diagnosed her ... Read more

This post was originally published on this siteThis post was originally published on this site The U.S. Food and Drug Administration (FDA) has ... Read more

This post was originally published on this siteThis post was originally published on this site The European Commission (EC) has approved Empliciti (elotuzumab) ... Read more

This post was originally published on this siteThis post was originally published on this site GlaxoSmithKline’s investigational antibody-drug conjugate, belantamab mafodotin (GSK2857916), demonstrated ... Read more

This post was originally published on this siteThis post was originally published on this site People in Japan newly diagnosed with multiple myeloma and ... Read more